|
|
 |
|
Viewing report
|
|
|
|
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Fuji-Keizai USA, Inc., Jan 2007, Pages: 155
1. What Cell Analysis is and What We Are Aiming for With This Research Project
1.1 Our Definition of the Cell Analysis Market
1.2 The Aim of This Research Report
2. Overview -- Current Market Status and R&D Status in Biotech and Pharma (Bio-Pharma) for Cell Analysis
2.1 Cell Based Screening & Analysis Helps Pharma Productivity
2.1.1 Drug Making Productivity
2.1.2 Increasing Use of Cell Based Screening and Analysis Platforms
2.2 Cell-Based Analysis Applications in Bio-Pharma Drug Discovery & Development
2.2.1 Traditional Pharma Drug Discovery Paradigm & Compound Screening
2.2.2 Drug Targets and Main Drug Target Classes
2.2.3 Cell Assay Development - Bio-pharmas Make Their Own Assays
2.2.4 High Throughput Screening (HTS) & High Content Screening (HCS)
2.2.5 Toxicology Testing (Safety Screening)
2.3 Current Equipment & Tools and R&D for Cell Analysis
2.4 Current Technologies and Related R&D for Cell Based Screening-Analysis
2.5 Current Reagents & Assays and Related R&D for Cell Based Screening-Analysis
2.6 Main Competitors by Large, Medium and Start-up (Emerging Companies)
3. Trends and Directions of Cell Based Screening and Analysis Equipment and Technologies
3.1 Trends: Cell Screening Equipment
3.1.1 Plate Imaging Equipment for Cell based HTS
3.1.2 Imaging Cytometry Equipment for HCS/ HCA
3.1.3 Emerging Developments In Cell Based Screening
3.2 Trends: Cell Screening Technologies
3.2.1 Labeling Reagents and No-Wash Assays
3.2.2 Cells as Reagents
3.2.3 Stem Cells Used as a Drug Discovery Tool
4. Alliances & IP
4.1 Summary and Review of Major M&As, Alliances, or Deals
4.1.1 M&A and Alliances at a Glance
4.1.2 Leading M&A Acquirers
4.1.3 Data Tables for M&As and Alliances Involving Cell-Based Analysis
4.2 Summary of Key Patent IP Involving Cell-Based Analysis
5. Market Size and Forecast 2006 to 2011
5.1 The Total Worldwide Cell-Based Screening-Analysis Market Size
5.2 Market Segments by Product Type and Revenues
5.2.1 Major Market Segments by Main Product Areas
5.2.2 Comparison of Major Market Segments by Market Shares, 2007& 2011
5.2.3 Equipment Segment by Product Type
5.2.4 'Consumables' Segment by Product Type
5.2.5 Content Segment by Product Type
5.2.6 Services Segment by Product Type
5.2.7 'Others' Segment by Product Type
5.3 Market Segments By Major Worldwide Regions
5.3.1 Region Segments
5.3.2 Comparison of Region Segments by Market Shares, 2007 & 2011
5.4 Outlook for Leading Commercial Vendors Market Share Rank
6. Activities of Cell Based Screening-Analysis Companies
6.1 Multiplatform Cell Screening/Analysis Systems
6.1.1 to 6.1.7 Total 7 companies
6.2 Flow Cytometry Screening Systems
6.2.1 to 6.2.4 Total 4 companies
6.3 High Content Screening/Analysis Cell Imaging Systems
6.3.1 to 6.3.5 Total 5 companies
6.4 Cell-Based Screening Assays/Reagents
6.4.1 to 6.4.5 Total 5 companies
6.5 Cell Screening Assays/Reagents
6.5.1 to 6.5.3 Total 3 companies
6.6 Contract Research and Development Services
6.6.1 to 6.6.3 Total 3 companies
6.7 Cell Screening/Analysis Software
6.7.1 to 6.7.4 Total 4 companies
7. Conclusions: Findings & Opportunities
7.1 Important Findings
7.1.1 Market Size and Growth
7.1.2 Alliances and IP
7.1.3 Bio-Pharma Product & Technology Users
7.1.4 Equipment
7.1.5 Services
7.2 The Cell-Based Screening & Analysis Business/ Tech Market Roadmap and Opportunities
7.2.1 Major CBSA Products & Services Segments by Growth Rate
7.2.2 Important Growth Areas Within Major Segments
8. Appendix
8.1 Company Contacts (Total 85 companies)
8.2 Patent Data Tables (Total 340 patents)
List of Tables
Table 1. Equipment for Cell Based Screening and Analysis
Table 2. Equipment Competitors by Large, Medium & Small Companies
Table 3. Consumables Competitors by Large, Medium & Small Companies
Table 4. Content Competitors by Large, Medium & Small Companies
Table 5. Services Competitors by Large, Medium & Small Companies
Table 6. Other Competitors by Large, Medium & Small Companies
Table 7. Wide Field vs. Confocal HCS/ HCA Equipment
Table 8. Confocal HCS/ HCA Imaging Equipment Used By Bio-Pharmas
Table 9. Summary of Cell-based M&As & Alliances, 2004 through 2006
Table 10. Summary of Cell-based M&As by Top Acquirers
Table 11. M&As and Alliances, 2006
Table 12. M&As and Alliances, 2005
Table 13. M&As and Alliances for Cell-Based Screening and Analysis, 2004
Table 14. CBA Related IP by No. of New Patents Issued, 2005 & 2006
Table 15. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma.
Drug Discovery & Development (BPDD)
Table 16. WW Market by Major Segments & Revenues
Table 17. WW Market by Major Segments & Shares, 2007 & 2011
Table 18. 'Equipment' Segments by Product Type
Table 19. 'Consumables' Segments by Type
Table 20. 'Content' Segments by Type
Table 21. 'Services' Segments by Type
Table 22. The 'Others' Segment
Table 23. CBSA Market by Major Worldwide Regions
Table 24. Market by Major Worldwide Region Share, 2007 & 2011
Table 25. Leading 'Equipment' Vendors by Est. Market Share Rank
Table 26. Leading 'Consumables' Vendors by Est. Market Share Rank
Table 27. Major CBSA Products & Services Segments by Growth Rate
Table 28. 'Services' Sub-segments by Growth Rate
Table 29. 'Consumables' Sub-segments by Growth Rate
Table 30. 'Equipment' Sub-segments by Growth Rate
Table 31. Company Contacts, Web Links and State/Country
Table 32. Patent Data by Technology Type, Company, Patent and Title
List of Illustrations
Figure 1. WW Cell Based Screening and Analysis by Products & Services
Figure 2. Traditional Drug Discovery and Development Paradigm
Figure 3. MDC FLIPR vs. Competing HTS Flash Luminescence Plate Imagers
Figure 4. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma.
Drug Discovery & Development (BPDD)
Figure 5. WW Market by Major Segments & Revenues
Figure 6. WW Market by Major Segments & Shares, 2007 & 2011
Figure 7. 'Equipment' Segments by Type
Figure 8. 'Consumables' Segments by Type
Figure 9. 'Content' Segments by Type
Figure 10. 'Services' Segments by Type
Figure 11. The 'Others' Segment
Figure 12. CBSA Market by Major Worldwide Regions
Figure 13. Market by Major Worldwide Region Share, 2007 & 2011
Figure 14. A Typical High Content Screening Solution
Figure 15. Molecular Devices Cell Based Screening Systems
Figure 16. Cellomics Imaging System for High Content Screening and Analysis
This title is also available in the following language
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery (Japanese Version)
Customers who bought this item also bought
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Cell-Based Assays for Drug Discovery
High Throughput Screening
hERG Screening
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
European Cell Based Assays Markets
U.S. High Content Screening Markets
High Content Screening (HCS): An Industry Analysis
Cell Therapy - Technologies, Markets and Companies
U.S. Cell-Based Assays Markets
Cell Therapy Markets
High-Throughput Screening in Drug Discovery
|
|
|
|
